LYMPHOCYTE-DEPLETING NONMYELOABLATIVE PREPARATIVE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS LYMPHOCYTE INFUSION, PEPTIDE VACCINE PLUS MONTANIDE ISA-51, AND INTERLEUKIN-2 IN TREATING PATIENTS WITH METASTATIC MELANOMA: